Formulation and Evaluation of Floating Matrix Tablets of Drotaverine Hydrochloride
Drotaverine Hydrochloride is effectively used in the treatment of management of spasticity, indicated in muscle pain as muscle relaxant. Drotaverine Hydrochloride approximately 95% bounds to plasma proteins and is metabolized by liver. In the present investigation, efforts were put to develop a sustained release floating matrix tablets of Drotaverine Hydrochloride. Gastro retentative dosage form will also greatly improve the pharmacotherapy of the stomach itself through local drug release leading to high drug concentrations at the gastric mucosa, which are sustained over a long period of time. Floating matrix tablets were prepared by direct compression method using sodium bicarbonate and citric acid as gas forming agents. HPMC K100M and Ethyl cellulose were used in the formula to retard drug release. Floating matrix tablets were evaluated for different quality attributes. In vitro drug release showed that polymer percentage is enough to extend the release of the drug for at least 12 hr. The dissolution curve shows that formulation FT-6 shows maximum drug release 79.37% at the end of 12 hours while FT-7 shows least 46.33 %.
2. Tanwar Y.S, Rana A.C, In, Formulation and Evaluation of Famotidine Floating Tablets. Current Drug Delivery, 2007,4,51 –55.
3. Prajapati S.T, Patel L.D, Patel D.M, In, Studies on Formulation and In Vitro Evaluation of Floating Matrix Tablets of Domperidone. Indian Journal of Pharmaceutical Sciences, 2009, 19 –23.
4. Sungthongjeen S, Sriamornsak P, In, Design and evaluation of floating multi-layer coated tablets based on gas formation. European Journal of Pharmaceutics and Biopharmaceutics 2008; 69:255–263.
5. Li S, Lin S,In, Statistical Optimization of Gastric Floating System for Oral Controlled Delivery of Calcium. AAPS Pharm Sci Tech 2001; 2:1 –12.
6. Robles L.V, Martínez IJ, In, Sustained delivery of captopril from floating matrix tablets. International Journal of Pharmaceutics 2008; 362:37–43.
7. Shah S.H, Patel J.K, Patel N.V, In, Stomach Specific Floating Drug Delivery System A Review. International Journal of Pharm Tech Research, 2009; 623 –633.
8. Singh BN, Kim KH. Floating drug delivery systems: An approach to Oral Controlled Drug Delivery via Gastric Retention. J Contr Rel, 2000; 63:235-59.
9. USP NF, The official compendia of standards, 4th edition, The United States Pharmacopeial convention, 2009; 2:320-324.
10. Scan C Sweet man, Martindale The complete drug Reference,, Thirty four edition, Published by the Pharmaceutical press, 1616-1618
11. Lachman, L., Liberman, H.A., Kanig, J.L., In., The Theory and Practice of Industrial Pharmacy, 3rd Ed., Varghese Publishing House, Bombay, 1987; 416-418, 430-453.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).